These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 17349271)
1. [Will academic research rescue the drug discovery crisis?]. Bouvier M Med Sci (Paris); 2007 Mar; 23(3):227-8. PubMed ID: 17349271 [No Abstract] [Full Text] [Related]
2. Drug development. Biotech thinking comes to academic medical centers. Alper J Science; 2003 Feb; 299(5611):1303-5. PubMed ID: 12610271 [No Abstract] [Full Text] [Related]
3. Preclinical drug discovery research and training at Vanderbilt. Lindsley CW; Weaver D; Jones C; Marnett L; Conn PJ ACS Chem Biol; 2007 Jan; 2(1):17-20. PubMed ID: 17243778 [No Abstract] [Full Text] [Related]
4. Drug discovery. Kennedy D Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461 [No Abstract] [Full Text] [Related]
6. Forging synergies in drug discovery. Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672 [No Abstract] [Full Text] [Related]
7. Partnership between academia and industry for drug discovery in Alzheimer's disease. Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952 [TBL] [Abstract][Full Text] [Related]
8. The Drug Discovery Portal: a resource to enhance drug discovery from academia. Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242 [TBL] [Abstract][Full Text] [Related]
9. Drug discovery: the leading edge. Chapman T Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608 [No Abstract] [Full Text] [Related]
10. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Tobbell DA Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387 [TBL] [Abstract][Full Text] [Related]
11. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required. Brewer GJ J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351 [No Abstract] [Full Text] [Related]
13. Strategic applications of toxicogenomics in early drug discovery. Ryan TP; Stevens JL; Thomas CE Curr Opin Pharmacol; 2008 Oct; 8(5):654-60. PubMed ID: 18760379 [TBL] [Abstract][Full Text] [Related]
14. [Strategy of molecular drug design: hits, leads and drug candidates]. Guo ZR Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779 [TBL] [Abstract][Full Text] [Related]
15. [The Innovative Medicine Initiative (IMI)]. Bril A; Canet E Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588 [TBL] [Abstract][Full Text] [Related]
17. The anti-intellectual effects of intellectual property. Lipinski CA Curr Opin Chem Biol; 2006 Aug; 10(4):380-3. PubMed ID: 16829159 [TBL] [Abstract][Full Text] [Related]
18. The future is much closer collaboration between the pharmaceutical industry and academic medical centers. Vallance P; Williams P; Dollery C Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455 [No Abstract] [Full Text] [Related]
19. China's unique position in discovery and preclinical research. Boutellier R; Ullman F Drug Discov Today; 2007 Jan; 12(1-2):4-7. PubMed ID: 17198968 [No Abstract] [Full Text] [Related]
20. A return to the fundamentals of drug discovery? Williams M Curr Opin Investig Drugs; 2004 Jan; 5(1):29-33. PubMed ID: 14983970 [No Abstract] [Full Text] [Related] [Next] [New Search]